Akèy › Dyabèt Tip 2 › Illinois › Chicago
Etid klinik pou Dyabèt Tip 2 nan Chicago, IL
19 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Ap rekriteFaz 3
- Cedar Crosse Research Center, Chicago
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Ap rekriteVolontè an sante akeyi
- Northwestern University, Chicago
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Ap rekriteFaz 3
- Cedar Crosse Research Center, Chicago
- Northwestern University, Chicago
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Ap rekriteFaz 3
- Research Site, Chicago
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Ap rekriteFaz 3
- Research Site, Chicago
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
Ap rekriteFaz 2
- AES - DRS - Synexus Clinical Research US, Inc. - Chicago, Chicago
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Ap rekriteFaz 2
- Cedar-Crosse Research Center, Chicago
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Ap rekriteFaz 2
- Research by Design, LLC - Internal Medicine, Chicago
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Ap rekriteFaz 2
- Chicago Clinical Research Institute, Chicago
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Ap rekriteFaz 3
- Research Site, Chicago
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
Ap rekriteFaz 3
- Research Site, Chicago
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
Ap rekriteFaz 1Volontè an sante akeyi
- Research Site, Chicago
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Ap rekriteFaz 3
- University of Illinois at Chicago, Chicago
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
Ap rekrite
- Northwestern University, Chicago
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
Ap rekrite
- Northwestern University, Chicago
Achieving Routine Intervention and Screening for Emotional Health
Ap rekrite
- University of Chicago, Chicago
Mathematical Modeling of Blood Sugar and Hormone Responses in Insulin-Dependent Type 2 Diabetes
Ap rekriteEtid obsèvasyon
- Illinois Institute of Technology, Chicago
Enhancing Diabetes Care: Exposome &Amp; Sensors
Ap rekriteEtid obsèvasyon
- University of Illinois - Chicago, Chicago
- University of Illinois College of Nursing, Chicago
My ESSENCE - A Research Study on Mindfulness for African-Americans With Type 2 Diabetes
Ap rekriteVolontè an sante akeyi
- University of Illinois at Chicago, Chicago
Etid Dyabèt Tip 2 nan lòt vil
- San Antonio, TX37 etid
- Houston, TX31 etid
- Orlando, FL24 etid
- Boston, MA20 etid
- Miami, FL19 etid
- Dallas, TX19 etid
- Columbus, OH18 etid
- Las Vegas, NV18 etid
- Atlanta, GA17 etid
- San Diego, CA17 etid
- Los Angeles, CA16 etid
- New York City, NY16 etid
Lòt etid nan Chicago
- Kansè Poumon ki pa ti selil61 etid
- Kansè nan tete58 etid
- Kansè (tout kalite)51 etid
- Kansè Metastatik45 etid
- Kansè pwostat45 etid
- Obèsite41 etid
- Kansè poumon41 etid
- Kansè ovè36 etid
- Akidan serebavaskilè34 etid
- Kansè kolorektal33 etid
- Ensifizyans kadyak31 etid
- Sipwa28 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.